Sleepiz AG (Ltd.), a Zürich-based startup, focuses on patient-centric disease management through seamless integration of contactless monitoring into homes. Leveraging sleep insights, our device, placed on the bedside table, operates non-contact and measures heart contractions, breathing patterns, and body motions with medical-grade accuracy. We have FDA 510(k) Class II clearance for vital sign monitoring and EU MDR CE Class IIa certification for vital signs and sleep apnea diagnosis. Whether in clinical settings or at home, Sleepiz’s solutions are designed to help identify health issues early, support managing chronic conditions, and enable remote patient monitoring (RPM). We’re dedicated to making healthcare more accessible and comfortable for everyone.

News

11.10.2023 FDA approval for SleepizOne+ device (startupticker.ch)
25.05.2022 ETH Spin-off Sleepiz schafft B2B-Markteintritt (startupticker.ch)
08.03.2022 Sleepiz closes Series A round at CHF 6,2 million (startupticker.ch)
27.08.2021 Sleepiz AG Raises CHF 4.4m (startupticker.ch)

Milestones/News

19.10.2020 Grant by Innosuisse
20.07.2020 ETH Spin-off
12.03.2020 ISO 13485 Certified
17.07.2019 Seal of Excellence - European Commission
29.05.2019 Seed Round

Videos and Presentations


Sleepiz Introduction